Gary Elfring
- Hepatology top 0.5%
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 9
- Lung Cancer Research Studies 9
- Cancer Treatment and Pharmacology 6
- Genetics top 2%
-
- Cystic Fibrosis Research Advances 9
- Molecular Biology top 5%
- Muscle Physiology and Disorders 40
- Cancer therapeutics and mechanisms 14
-
- Biotin and Related Studies 6
-
- Cardiomyopathy and Myosin Studies 5
- Co-authors
- Langdon L. MillerPaula K. LockerLeonard B. SaltzNicoletta PirottaJohn V. CoxStephen P. AcklandLee S. RosenCharles D. Blanke
- Cited by
- HepatologyOncologyGenetics
- Journals
- Neuromuscular Disorders (16 papers)Journal of Clinical Oncology (13 papers)Journal of Cystic Fibrosis (9 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Gary Elfring
87 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Hepatology 1.0k
- Oncology 3.1k
- Genetics 510
- Pulmonary and Respiratory Medicine 1.5k
- Molecular Biology 2.4k
Countries citing papers authored by Gary Elfring
This map shows the geographic impact of Gary Elfring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Elfring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Elfring more than expected).
Fields of papers citing papers by Gary Elfring
This network shows the impact of papers produced by Gary Elfring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Elfring. The network helps show where Gary Elfring may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gary Elfring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 5 | |
| 2 | 2019 | 1 | |
| 3 | 2016 | 2 | |
| 4 | 2016 | 2 | |
| 5 | 2013 | 172 | |
| 6 | 2011 | 151 | |
| 7 | 2011 | 11 | |
| 8 | 2010 | 184 | |
| 9 | 2009 | 283 | |
| 10 | 2008 | 290 | |
| 11 | 2007 | 7 | |
| 12 | 2007 | 188 | |
| 13 | 2003 | 88 | |
| 14 | 2001 | 32 | |
| 15 | 2001 | 3 | |
| 16 | Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancerbreakdown → | 2000 | 2368 |
| 17 | 1999 | 162 | |
| 18 | 1998 | 48 | |
| 19 | 1994 | 21 | |
| 20 | 1972 | 1 |
About Gary Elfring
Gary Elfring is a scholar working on Oncology, Molecular Biology and Hepatology, having authored 93 papers that have together received 5.9k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (40 papers), Cancer therapeutics and mechanisms (14 papers), Cystic Fibrosis Research Advances (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Research Studies (9 papers), Biotin and Related Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Cardiomyopathy and Myosin Studies (5 papers). The work is most often cited by research in Hepatology (1.0k citations), Oncology (3.1k citations) and Genetics (510 citations). Gary Elfring has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Langdon L. Miller, Paula K. Locker, Leonard B. Saltz, Nicoletta Pirotta, John V. Cox, Stephen P. Ackland, Lee S. Rosen, Charles D. Blanke, Jean A. Maroun and Malcolm J. Moore. Their work appears in journals such as Neuromuscular Disorders, Journal of Clinical Oncology, Journal of Cystic Fibrosis, Neurology and Muscle & Nerve.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.